• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Immunol . ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling

tetano

Editor, Senior Moderator
J Immunol


. 2021 Nov 24;ji2100742.
doi: 10.4049/jimmunol.2100742. Online ahead of print.
ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling


Beibei Wu[SUP] 1 [/SUP], Arunachalam Ramaiah[SUP] 2 3 [/SUP], Gustavo Garcia Jr[SUP] 4 [/SUP], Spyridon Hasiakos[SUP] 1 5 [/SUP], Vaithilingaraja Arumugaswami[SUP] 6 7 8 [/SUP], Sonal Srikanth[SUP] 9 [/SUP]



Affiliations

Abstract

ORAI1 and stromal interaction molecule 1 (STIM1) are the critical mediators of store-operated Ca[SUP]2+[/SUP] entry by acting as the pore subunit and an endoplasmic reticulum-resident signaling molecule, respectively. In addition to Ca[SUP]2+[/SUP] signaling, STIM1 is also involved in regulation of the type I IFN (IFN-I) response. To examine their potential role in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, we generated ORAI1 and STIM1 knockout human HEK293-angiotensin-converting enzyme 2 cells and checked their responses. STIM1 knockout cells showed strong resistance to SARS-CoV-2 infection as a result of enhanced IFN-I response. On the contrary, ORAI1 deletion induced high susceptibility to SARS-CoV-2 infection. Mechanistically, ORAI1 knockout cells showed reduced homeostatic cytoplasmic Ca[SUP]2+[/SUP] concentration and severe impairment in tonic IFN-I signaling. Transcriptome analysis showed downregulation of multiple antiviral signaling pathways in ORAI1 knockout cells, likely because of reduced expression of the Ca[SUP]2+[/SUP]-dependent transcription factors of the AP-1 family and MEF2C Accordingly, modulation of homeostatic Ca[SUP]2+[/SUP] concentration by pretreatment with ORAI1 blocker or agonist could influence baseline IFNB expression and resistance to SARS-CoV-2 infection in a human lung epithelial cell line. Our results identify a novel role of ORAI1-mediated Ca[SUP]2+[/SUP] signaling in regulating the tonic IFN-I levels, which determine host resistance to SARS-CoV-2 infection.
 
Back
Top Bottom